Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-23-007183
Filing Date
2023-05-24
Accepted
2023-05-24 17:14:52
Documents
1
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1320
  Complete submission text file 0001654954-23-007183.txt   2741
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25801 INDUSTRIAL BLVD. SUITE B HAYWARD CA 94545
Business Address
Olson Charles V (Reporting) CIK: 0001663298 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37619 | Film No.: 23955081